<img src="https://secure.intelligence52.com/795232.png" style="display:none;">

Blog

Adaptive Trial Design in Clinical Development: Benefits, Limits & Use Cases

By Statistical Consultancy Team
March 20, 2026
Explore adaptive trial design in clinical development, including benefits, limits, use cases, interim analyses, Bayesian methods, and reporting.
Learn more

The Importance of Defining Clinical Trial Performance Metrics

By Commercial Team
March 13, 2026
Learn how clinical trial performance metrics help teams track study delivery, manage risk, and improve decision-making across start-up, conduct, and closeout.
Learn more

Clinical Trial Simulation: Models, Workflows, and Common Pitfalls

By Statistical Consultancy Team
March 9, 2026
Learn how to use clinical trial simulation to test design assumptions, explore risk, and support dose, endpoint, and operational choices before enrolment.
Learn more

Oncology Phase 1 Trial Design: A Comprehensive Guide

By Statistical Consultancy Team
March 6, 2026
A practical guide to oncology Phase 1 trial design, covering dose-finding, escalation, biomarkers, and the operational realities of early cancer trials.
Learn more

What is a Retrospective Observational Study?

By Statistical Consultancy Team
February 25, 2026
Understand what a retrospective observational study is, what ‘retrospective’ changes in practice, and how to interpret findings with the right level of caution.
Learn more

FSP Models in Clinical Trials: Types, Differences & Key Considerations

By Commercial Team
February 19, 2026
Understand FSP models in clinical trials, including common model types, key differences from full-service outsourcing, and the practical considerations.
Learn more

How to Conduct an Observational Study

By Statistical Consultancy Team
February 17, 2026
Learn how to conduct an observational study with steps for design, data collection, analysis planning, and a write-up format for transparent reporting.
Learn more

What is the FDA's Technical Rejection Criteria for Study Data?

By Clinical Programming Team
February 13, 2026
Understand the FDA’s Technical Rejection Criteria for study data submissions, common failure points in eCTD structure, and practical steps to reduce risk.
Learn more

Regulatory Submissions in Clinical Trials: Types, Steps & Common Pitfalls

By Clinical Programming Team
February 11, 2026
What are regulatory submissions in clinical trials? Key submission types, practical steps to build and validate the package, and common pitfalls.
Learn more

Observational vs Experimental Studies

By Commercial Team
January 22, 2026
Understand the difference between observational and experimental studies, how each supports causality, and how to identify the design in practice.
Learn more

A Guide to Observational Studies in Clinical Trials

By Statistical Consultancy Team
January 14, 2026
Learn what observational studies are, key types, common biases, and statistical approaches to support credible real-world evidence.
Learn more

Clinical Study Start Up: Process, Key Challenges & How to Avoid Delays

By Commercial Team
January 6, 2026
Clinical study start up prepares a trial for enrolment. Learn the process, key roles, common delays, and how to improve timelines with better control.
Learn more

Subscribe to the Blog